In this article, we outline actionable strategies for strengthening one of the most essential administrative data ...

The “it’s the prices” narrative focuses attention on a set of fee-schedule-oriented policies (some of which, as noted above, I support). The concern I have is that this narrative focuses attention ...

While the value of HF/SE in improving patient safety has been demonstrated, the field remains significantly underused and not well understood. 9 In this article we describe HF/SE, its different facets ...

With a growing demand for mental health and substance use disorder services, states should think creatively about policies to extend and grow the workforce.

Andrew W. Mulcahy ([email protected]), RAND, Arlington, Virginia. US prices for brand-name drugs are substantially higher than those in other countries. Recent “most favored nation” proposals aim to ...

Multi-year coverage potentially improves the value of insurance by making it easier for insurers to pool high- and low-risk ...

It is not currently understood whether the COVID-19 pandemic led to a lengthy period of elevated mortality rates or whether rates have returned to prepandemic trends. To examine this, I calculated age ...

Maryland hospitals have operated under all-payer global budget models since 2014. Within Medicare, evaluations have estimated the resulting cost savings to be $1.6 billion for the period 2014–22. To ...

The FDA should improve device safety by increasing the amount and availability of information about previously marketed ...

The US pays higher drug prices than do peer nations, thereby financing a disproportionate share of global pharmaceutical research and development. President Donald Trump has announced himself willing ...

Medicare’s opioid treatment benefit unintentionally encourages underuse of psychosocial services. The authors propose a ...